Minimally Invasive Esophagectomy Offers Benefits

Share this article:
Minimally Invasive Esophagectomy Offers Benefits
Minimally Invasive Esophagectomy Offers Benefits

(HealthDay News) – Compared with open transthoracic esophagectomy, minimally invasive transthoracic esophagectomy is associated with significantly fewer pulmonary infections and with other short-term benefits in patients with resectable cancer of the esophagus.

Surya S.A.Y. Biere, MD, of the VU University Medical Centre in Amsterdam, and colleagues conducted a multicenter, open-label, randomized controlled study involving 115 patients with resectable cancer of the esophagus or gastro-esophageal junction who were treated with either open transthoracic or minimally invasive transthoracic esophagectomy.

The researchers found that, overall, the rate of pulmonary infections within the first two weeks was nearly 70% lower in the minimally invasive group compared with those who received an open esophagectomy (9 vs. 29%). Similarly, the rate of pulmonary infection in-hospital was 65% lower in the minimally invasive vs. open esophagectomy groups (12 vs. 34%). In-hospital mortality was similar for the groups, with one patient death in the open esophagectomy group from an anastomotic leakage, and two in the minimally invasive group (one from aspiration and one from mediastinitis following anastomotic leakage).

"A shorter hospital stay in the minimally invasive group in our trial indicates a faster postoperative recovery than in the open esophagectomy group," the authors write. "In conclusion, our findings provide evidence for the short-term benefits of minimally invasive compared with open esophagectomy for patients with resectable esophageal cancer."

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs